Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. ReproNovo
ReproNovo is a biotechnology company that develops therapies focused on reproductive medicine and women’s health. Its programs target conditions including male infertility, embryo implantation challenges, and adenomyosis.
- Sector: Health Care
- Last known transaction date: Series A Venture, $65M, May 2025
- Why timing suggests a near-term transaction: ReproNovo’s $65M Series A announced in May 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A biotechnology companies preparing for their next growth round. Given the size of the round and focus on reproductive health therapeutics, the company is likely to evaluate follow-on capital, strategic biopharma partnerships, or acquisition interest as clinical development and pipeline validation progress.
View all private company data in Dakota Marketplace.
2. Biostate AI
Biostate AI is a biotechnology company specializing in AI-driven solutions for the life sciences and healthcare sectors. Founded in 2023 by David Zhang and Ashwin Gopinath, the company is headquartered in Houston, Texas. Biostate AI focuses on developing advanced RNA and DNA sequencing technologies to enhance precision medicine and disease prediction. Their key products include a high-fidelity RNA and DNA sequencing platform and K-Dense, an autonomous AI scientist designed to accelerate research cycles. The leadership team comprises experts from institutions like Caltech and MIT, with a mission to revolutionize healthcare through innovative AI applications.
- Sector: Healthcare AI / Molecular Diagnostics / Genomics
- Last known transaction date: Series A, $12M, May 2025
- Why timing suggests a near-term transaction: Biostate AI recently closed a sizable Series A round and is operating in the rapidly expanding AI-driven genomics and precision medicine market. The company is building a large-scale RNA sequencing dataset intended to train foundation models for molecular diagnostics and therapeutic discovery, positioning it within a highly active funding environment for AI-native biotech platforms. Its combination of proprietary sequencing infrastructure, AI research tools such as K-Dense, and backing from notable investors and strategic angels (including leadership from Anthropic, 10x Genomics, and Twist Bioscience) suggests continued momentum toward additional venture financing, strategic partnerships, or potential platform expansion transactions in the near-to-medium term.
View all private company data in Dakota Marketplace.
3. Pay-i
Doji is a New York City-based startup founded in 2024, aiming to redefine the fashion shopping experience by integrating elements of social media platforms like Instagram and TikTok. The company targets fashion-forward individuals who seek a personalized and expressive shopping journey. By leveraging advanced AI research and a deep understanding of contemporary culture, Doji offers a platform where fashion is not merely a product to purchase but a process of self-discovery and expression. The business model likely involves monetizing through partnerships with fashion brands and possibly through in-app purchases or advertising. With backing from investors associated with OpenAI, Cursor, and SKIMS, Doji is positioned to create a new paradigm in fashion retail, focusing on craft, curiosity, and the courage to innovate.
- Sector: Financials
- Last known funding round: Seed Venture, $4.9M, May 2025
- Why timing suggests a near-term transaction: The company’s $4.9M seed round announced in May 2025 places it approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage companies begin preparing for their next raise. As product development, early customer traction, and commercialization efforts progress, the company is likely to evaluate follow-on capital, strategic partnerships, or early acquisition interest.
View all private company data in Dakota Marketplace.
4. Alt Carbon
Alt Carbon is an India-based carbon removal company founded in 2023 that uses enhanced rock weathering to capture carbon dioxide and improve agricultural soil quality. The company applies basalt rock dust to farmland to support carbon sequestration and soil nutrient enhancement.
- Sector: Materials
- Last known funding round: Seed Venture, $12M, May 2025
- Why timing suggests a near-term transaction: Alt Carbon’s $12M seed round announced in May 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage climate technology companies begin preparing for their next raise. As carbon removal projects scale and partnerships within the climate and industrial ecosystem expand, the company is likely to evaluate follow-on capital, strategic investment, or early acquisition interest.
View all private company data in Dakota Marketplace.
5. Alfadocs
AlfaDocs is a Munich-based healthcare software company founded in 2016 that provides a cloud-based practice management platform for dental and medical offices. Its software includes appointment scheduling, digital document management, patient communication, and workflow automation tools designed to improve administrative efficiency.
- Sector: Health Care
- Last known funding round: Venture Series A, $4.2M, May 2025
- Why timing suggests a near-term transaction: AlfaDocs’ $4.2M Series A announced in May 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A healthcare technology companies preparing for their next growth round. As provider adoption, platform usage, and healthcare partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
